Mei-Ling Cheng

Mei-Ling Cheng received the Ph.D. degree from the Department of Biochemistry, National Taiwan University, Taipei, Taiwan, in 2000. She began her Postdoctoral Fellow at Chang Gung University, Taoyuan, Taiwan, and Chang Gung Memorial Hospital, Taoyuan. As the Head of the Metabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, she oversees a team of experts developing and applying novel analytical methodologies for global profiling and targeted analysis of small molecules and lipids. Our favored technology platforms include nuclear magnetic resonance spectrometry (NMR), liquid chromatography time of fly mass spectrometry (LC-TOFMS), LC-tandem mass spectrometry (LC-MS/MS), and gas chromatography spectrometry (GC-MS). Our principal application of established and developing technologies includes human biofluids, tissue extracts, animal models, and cell cultures needed to explore disease mechanisms in greater depth. She works closely with clinicians and basic science researchers at the Chang Gung system to provide innovative and reliable bioanalytical solutions for metabolomics and lipidomics. She has published over 100 research articles in peer-reviewed and internationally renowned journals. Her research interests include redox biology and translational medicine. The well-established approach of both NMR- and MS-based metabolomics platforms has been applied to study the metabolic disturbance in disease, stress-induced metabolic reprogramming in cells, and age-related diseases.